Skip to content

STEVENS PHARMA

Active Public limited companyfounded 1990active for 36 yearsMechelsesteenweg 130, 1970 Wezembeek-OppemKBO/BCE: BE 0442.284.960 subsidiary of #8 oldest company in Wezembeek-Oppem, Wholesale and retail trade sector

Lifetime

20 annual accounts with figures on one time axis, 35 filings since 1991
peak of €165,069 in 2025
€165,069▲ 23.9%
lowest -€6,336 in 2011
€39,269▲ 65.5%
peak of €348,105 in 2020
€324,659▲ 13.8%
€81,843▼ 50.5%
peak of 2.5 FTE in 2009
1.3 FTEunchanged
Board4 names since 2013
1 director
Owners
  
Documentsfilings and deeds
13-07-202618 days before the deadline
2025abbreviated format
Gross margin from €133,277 to €165,069Result from €23,727 to €39,269Equity from €285,391 to €324,659Debts from €165,176 to €81,843

Key points

from the 2025 annual accounts

Equity

€324,659 ▲ 13.8%

STEVENS PHARMA has made a profit without a break since 2012.

Liquidity

4.06 was 2.21 in 2024

Short-term debts fell from €165,176 to €81,843.

Filings

35 annual accounts since 1991
AprilJune31 JulyOctober200020102020

Five of the last ten came late. The 2019 accounts came in latest, 138 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,389 companies had the same profile as STEVENS PHARMA has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,389 companies, not a prediction for STEVENS PHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • consolidatesannual accounts 2013
Board & ownership

Recent changes

2 directors resigning, 1 reappointment and resign · reappointed as sole director · “Het voeren van alle activiteiten die normaal behoren tot deze van de uitbating van een officina-apotheek…” (deed in Dutch) · Gazette deed
1 director resigning, 2 reappointments (managing director) and reappointed · resigns · Board meeting of 18-06-2019 · Gazette deed
1 director appointed, 1 resignation, 2 reappointments resigns · acts as permanent representative · appointed as managing director · General meeting of 23-12-2013 · Gazette deed
First establishment APOTEEK, Mechelsesteenweg 130, Wezembeek-Oppem
All 44 events

Comparable companies

same main activity, similar in size and age
Company
STEVENS PHARMA Wezembeek-Oppem €406,503 €165,069 79.9% 1.3
APOTHEEK NOSSEGEM Zaventem €470,305 €160,831 50.7% 1
APOTHEEK HERBRAND Leuven €417,097 €148,330 65.1% 1.4
APOTHEEK VICKY de CLIPPELE Lierde €394,212 €190,598 74.3% 1.4
Apotheek De Geyter Zottegem €432,080 €144,490 31.8% 1.1
VIESVILLE PHARMA Pont-à-Celles €470,253 €136,618 83.7% 1.2
APOTHEEK LEURIDAN A. Antwerp €414,648 €206,449 63.6% 1.5

These companies have the same main activity as STEVENS PHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €394,000 and €470,000, founded between 1985 and 1999.

Official details

Source: KBO
Status
Active since 17-10-1990Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2024
Establishment unit
2.056.521.7441970 Wezembeek-Oppem, since 06-03-1992
Financial year end
31 December
Peppol
Reachable via Peppol
Company details

Annual accounts 2025

≈ €780,000estimated
€406,503▼ 9.8%
Employeeson 31-12-2025
2=
Filing
Filed on 13-07-2026, 18 days before the end of the filing period
Financials

Insights on STEVENS PHARMA

STEVENS PHARMA files the abbreviated format. That format states no turnover. The gross margin rose from €113,565 in 2006 to €165,069 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about STEVENS PHARMA

What is the company number of STEVENS PHARMA?
The company number of STEVENS PHARMA is 0442.284.960. The VAT number is the same number with BE in front: BE 0442.284.960.
Where is STEVENS PHARMA based?
The registered office is at Mechelsesteenweg 130, 1970 Wezembeek-Oppem.Company details
What does STEVENS PHARMA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of STEVENS PHARMA?
STEVENS PHARMA is a public limited company (NV).
When was STEVENS PHARMA founded?
STEVENS PHARMA was founded on 17-10-1990.
Is STEVENS PHARMA still active?
Yes, STEVENS PHARMA is an active enterprise in the KBO register.
How many employees does STEVENS PHARMA have?
STEVENS PHARMA had an average of 1.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does STEVENS PHARMA fall under?
In its 2024 annual accounts, STEVENS PHARMA states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of STEVENS PHARMA?
The turnover in financial year 2025 is about €780,000. This figure is estimated from the gross margin of €165,069 and 43 comparable companies (NACE 477). It probably lies between €510,000 and €1.6m.
Is STEVENS PHARMA profitable?
In financial year 2025, STEVENS PHARMA made a profit of €39,269.
Where can I find the annual accounts of STEVENS PHARMA?
STEVENS PHARMA filed 35 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of STEVENS PHARMA due?
STEVENS PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.